Longevity Health Holdings, Inc.
For the period ended Dec 31, 2025. Filed Mar 31, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 31, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Longevity Health Holdings, Inc. | ||
| Date: March 31, 2026 | By: | /s/ Janakiram Ajjarapu |
|---|---|---|
| Name: Janakiram Ajjarapu | ||
| Chief Executive Officer and Chairman | ||
| (Principal Executive Officer) | ||
| Date: March 31, 2026 | By: | /s/ Bryan J. Cassaday |
| Name: Bryan J. Cassaday | ||
| Chief Financial Officer | ||
| (Principal Financial and Accounting Officer) | ||
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.
| Name | Title | Date |
|---|---|---|
| /s/ Janakiram Ajjarapu | Chief Executive Officer and Chairman | March 31, 2026 |
| Janakiram Ajjarapu | (Principal Executive Officer) | |
| /s/ Bryan J. Cassaday | Chief Financial Officer | March 31, 2026 |
| Bryan Cassaday | (Principal Financial and Accounting Officer) | |
| /s/ Scott Frisch | Director | March 31, 2026 |
| Scott Frisch | ||
| /s/ Kathryn Gregory | Director | March 31, 2026 |
| Kathryn Gregory | ||
| /s/ Gilles Spenlehauer | Director | March 31, 2026 |
| Gilles Spenlehauer | ||
| /s/ Patrick Sturgeon | Director | March 31, 2026 |
| Patrick Sturgeon | ||
| /s/ Richard Upton | Director | March 31, 2026 |
| Richard Upton | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.